APA (7th ed.) Citation

A, Y., SI, H., R, C., D, G., S, M., S, G., & P, D. (2003). Sequence dependent exposure of mammary carcinoma cells to Taxotere and the MEK1/2 inhibitor U0126 causes enhanced cell killing in vitro. Cancer biology & therapy, 2(6), 670.

Chicago Style (17th ed.) Citation

A, Yacoub, Han SI, Caron R, Gilfor D, Mooberry S, Grant S, and Dent P. "Sequence Dependent Exposure of Mammary Carcinoma Cells to Taxotere and the MEK1/2 Inhibitor U0126 Causes Enhanced Cell Killing in Vitro." Cancer Biology & Therapy 2, no. 6 (2003): 670.

MLA (9th ed.) Citation

A, Yacoub, et al. "Sequence Dependent Exposure of Mammary Carcinoma Cells to Taxotere and the MEK1/2 Inhibitor U0126 Causes Enhanced Cell Killing in Vitro." Cancer Biology & Therapy, vol. 2, no. 6, 2003, p. 670.